Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2025-12-25 @ 1:11 PM
NCT ID: NCT03917459
Description: Any sign or symptom that occurs during the study treatment plus the 30 days post treatment.
Frequency Threshold: 5
Time Frame: Adverse Events were collected from first dose of study treatment until end of study treatment plus 30 days post treatment, up to a maximum duration of approximately 2 years, 1 month
Study: NCT03917459
Study Brief: COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
LCZ696 LCZ696 200 mg (sacubitril/valsartan 97 mg/103 mg) bid 0 None 1 13 7 13 View
Enalapril Enalapril 10 mg bid 0 None 1 14 5 14 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cardiac arrest SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (24.0) View
Hypertensive crisis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (24.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (24.0) View
Blood potassium decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA (24.0) View
Fluid retention SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (24.0) View
Dental caries SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (24.0) View
Toothache SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (24.0) View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA (24.0) View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.0) View
Gout SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (24.0) View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (24.0) View
Haematoma SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (24.0) View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (24.0) View